MoonLake Immunotherapeutics earnings per share and revenue

MLTX earnings per share for the last quarter are -0.56 USD whereas the estimation was -0.44 USD which accounts for -28.60% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.60 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of MLTX earnings per share and revenue dynamics.